Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Regulation01:25

Drug Regulation

1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

721
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
721
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157
Pharmacovigilance01:19

Pharmacovigilance

826
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
826
Drug Classes and Categories01:25

Drug Classes and Categories

2.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
2.0K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Environmental considerations in human genomic data governance: overcoming normative challenges.

BMC medical ethics·2026
Same author

How Can the Law Keep Up? The Challenges in Regulating Health Innovations through the Lens of Embryo Research.

Journal of law and medicine·2025
Same author

Should Australian laws regulating embryo research be reformed? A call for commonwealth review.

Australian health review : a publication of the Australian Hospital Association·2025
Same author

Why Stop at a Right to Notice for AI Systems Used in Patient Care? The Need for Greater Specificity.

The American journal of bioethics : AJOB·2025
Same author

Patient-driven personal importation in the face of cost barriers to care: can we do better?

Internal medicine journal·2025
Same author

Do Doctors Have a Responsibility to Challenge the Distorting Influence of Commerce on Healthcare Delivery? The Case of Assisted Reproductive Technology.

Health care analysis : HCA : journal of health philosophy and policy·2024

相关实验视频

Updated: Jun 27, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

药物重用计划 - - 一个批判性的视角

Narcyz Ghinea1

  • 1Philosophy Department, Faculty of Arts, Ethics and Agency Research Centre, Macquarie University, North Ryde, NSW 2109, Australia.

Australian health review : a publication of the Australian Hospital Association
|May 6, 2024
PubMed
概括

新的药物改用计划支持非标签药物用于公共卫生. 然而,商业赞助商可能会过度影响哪些治疗是优先考虑的,从而危及计划.

科学领域:

  • 卫生政策 卫生政策
  • 制药经济学 制药经济学
  • 药物开发 药物开发

背景情况:

  • 药物重定位计划于2024年3月1日启动.
  • 解决了非标签药物的使用,具有显著的公共健康益处.
  • 旨在补贴缺乏商业赞助商财务激励的治疗.

研究的目的:

  • 为了提供药品重用计划的概述.
  • 批判性地分析程序的结构和潜在的风险.
  • 为已识别的问题提出缓解策略.

主要方法:

  • 对药品重用计划框架的审查.
  • 对赞助商对优先级制定的影响进行批判性分析.
  • 为降低风险制定建议.

主要成果:

  • 该计划为有益的非标签药物注册和补贴提供了一条途径.
  • 商业赞助商仍然对治疗优先级有很大的影响.
  • 由于金融激励,存在偏见的可能性.

结论:

  • 该计划有可能促进重要的公共卫生倡议.

更多相关视频

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

10.8K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K

相关实验视频

Last Updated: Jun 27, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

10.8K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
  • 必须建立机制,以确保对非标签药物的公正优先考虑.
  • 需要采取缓解策略,以应对赞助商的影响,并确保公平获取.